HIGHLIGHTS
- who: Kazumichi Kawakubo from the Department of Gastroenterology and Hepatology, Faculty of University, Sapporo, Japan have published the research: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy, in the Journal: (JOURNAL)
SUMMARY
Epigenetic regulation of gene_expression includes the post-translational modification of histone proteins and methylation of DNA. Immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and programmed cell death 1/programmed death ligand 1 (PD1/ PDL1) have been used with great success in several cancers and are now widely accepted as one of the standard therapies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.